Dopamine-responsive dystonia: Difference between revisions
CSV import |
CSV import |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Dopamine-responsive dystonia | |||
| synonyms = Segawa syndrome | |||
| field = [[Neurology]] | |||
| symptoms = [[Muscle contractions]], [[tremor]], [[gait abnormalities]] | |||
| onset = Childhood | |||
| duration = Lifelong | |||
| causes = Genetic mutations in [[GCH1]], [[TH]], or [[SPR]] genes | |||
| risks = Family history | |||
| diagnosis = Clinical evaluation, [[genetic testing]], [[levodopa]] trial | |||
| differential = [[Cerebral palsy]], [[Parkinson's disease]], [[dystonia]] | |||
| treatment = [[Levodopa]], [[dopamine agonists]] | |||
| prognosis = Good with treatment | |||
| frequency = Rare | |||
}} | |||
'''Dopamine-responsive dystonia''' (DRD) is a [[neurological disorder]] that affects the [[nervous system]] and causes [[muscle]] stiffness and involuntary [[muscle contraction]]s. It is a rare condition that typically begins in childhood and can lead to significant physical disability. | '''Dopamine-responsive dystonia''' (DRD) is a [[neurological disorder]] that affects the [[nervous system]] and causes [[muscle]] stiffness and involuntary [[muscle contraction]]s. It is a rare condition that typically begins in childhood and can lead to significant physical disability. | ||
== Symptoms == | == Symptoms == | ||
The symptoms of dopamine-responsive dystonia can vary greatly from person to person. They typically begin in childhood and may include: | The symptoms of dopamine-responsive dystonia can vary greatly from person to person. They typically begin in childhood and may include: | ||
* [[Muscle stiffness]] | * [[Muscle stiffness]] | ||
* Involuntary [[muscle contraction]]s | * Involuntary [[muscle contraction]]s | ||
| Line 12: | Line 25: | ||
* [[Depression]] | * [[Depression]] | ||
* [[Anxiety]] | * [[Anxiety]] | ||
== Causes == | == Causes == | ||
Dopamine-responsive dystonia is caused by a deficiency of the [[neurotransmitter]] [[dopamine]] in the brain. This can be due to a genetic mutation in the GCH1 gene, which is involved in the production of dopamine. However, in some cases, the cause of the condition is unknown. | Dopamine-responsive dystonia is caused by a deficiency of the [[neurotransmitter]] [[dopamine]] in the brain. This can be due to a genetic mutation in the GCH1 gene, which is involved in the production of dopamine. However, in some cases, the cause of the condition is unknown. | ||
== Diagnosis == | == Diagnosis == | ||
Diagnosis of dopamine-responsive dystonia is based on the presence of characteristic symptoms and a positive response to treatment with [[levodopa]], a medication that increases the levels of dopamine in the brain. Genetic testing may also be used to confirm the diagnosis. | Diagnosis of dopamine-responsive dystonia is based on the presence of characteristic symptoms and a positive response to treatment with [[levodopa]], a medication that increases the levels of dopamine in the brain. Genetic testing may also be used to confirm the diagnosis. | ||
== Treatment == | == Treatment == | ||
Treatment for dopamine-responsive dystonia primarily involves medication to increase the levels of dopamine in the brain. This typically includes [[levodopa]] and [[carbidopa]], which are often effective in reducing symptoms. In some cases, other medications or therapies may be used. | Treatment for dopamine-responsive dystonia primarily involves medication to increase the levels of dopamine in the brain. This typically includes [[levodopa]] and [[carbidopa]], which are often effective in reducing symptoms. In some cases, other medications or therapies may be used. | ||
== Prognosis == | == Prognosis == | ||
With appropriate treatment, most individuals with dopamine-responsive dystonia can lead normal lives. However, the condition is chronic and requires ongoing management to control symptoms. | With appropriate treatment, most individuals with dopamine-responsive dystonia can lead normal lives. However, the condition is chronic and requires ongoing management to control symptoms. | ||
== See also == | == See also == | ||
* [[Dystonia]] | * [[Dystonia]] | ||
* [[Neurological disorder]] | * [[Neurological disorder]] | ||
* [[Dopamine]] | * [[Dopamine]] | ||
* [[Levodopa]] | * [[Levodopa]] | ||
[[Category:Neurological disorders]] | [[Category:Neurological disorders]] | ||
[[Category:Genetic disorders]] | [[Category:Genetic disorders]] | ||
[[Category:Rare diseases]] | [[Category:Rare diseases]] | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
{{No image}} | |||
Latest revision as of 05:10, 4 April 2025
| Dopamine-responsive dystonia | |
|---|---|
| Synonyms | Segawa syndrome |
| Pronounce | N/A |
| Specialty | N/A |
| Symptoms | Muscle contractions, tremor, gait abnormalities |
| Complications | N/A |
| Onset | Childhood |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutations in GCH1, TH, or SPR genes |
| Risks | Family history |
| Diagnosis | Clinical evaluation, genetic testing, levodopa trial |
| Differential diagnosis | Cerebral palsy, Parkinson's disease, dystonia |
| Prevention | N/A |
| Treatment | Levodopa, dopamine agonists |
| Medication | N/A |
| Prognosis | Good with treatment |
| Frequency | Rare |
| Deaths | N/A |
Dopamine-responsive dystonia (DRD) is a neurological disorder that affects the nervous system and causes muscle stiffness and involuntary muscle contractions. It is a rare condition that typically begins in childhood and can lead to significant physical disability.
Symptoms[edit]
The symptoms of dopamine-responsive dystonia can vary greatly from person to person. They typically begin in childhood and may include:
- Muscle stiffness
- Involuntary muscle contractions
- Tremors
- Difficulty walking
- Speech difficulties
- Depression
- Anxiety
Causes[edit]
Dopamine-responsive dystonia is caused by a deficiency of the neurotransmitter dopamine in the brain. This can be due to a genetic mutation in the GCH1 gene, which is involved in the production of dopamine. However, in some cases, the cause of the condition is unknown.
Diagnosis[edit]
Diagnosis of dopamine-responsive dystonia is based on the presence of characteristic symptoms and a positive response to treatment with levodopa, a medication that increases the levels of dopamine in the brain. Genetic testing may also be used to confirm the diagnosis.
Treatment[edit]
Treatment for dopamine-responsive dystonia primarily involves medication to increase the levels of dopamine in the brain. This typically includes levodopa and carbidopa, which are often effective in reducing symptoms. In some cases, other medications or therapies may be used.
Prognosis[edit]
With appropriate treatment, most individuals with dopamine-responsive dystonia can lead normal lives. However, the condition is chronic and requires ongoing management to control symptoms.
